Subscribe
Logo small
Search

Author of entries: Katarzyna Czyżewska

Adwokat Katarzyna Czyżewska: wspólnik w Czyżewscy kancelaria adwokacka, posiada wieloletnie doświadczenie w doradztwie na rzecz podmiotów z sektora szeroko pojętych Life Sciences.
Katarzyna-Czyzewska-nowe2
Katarzyna Czyzewska

Forecast for 2024: what changes in the law may await the pharmaceutical industry?

The turn of the year prompts summaries and reflections on what has passed and what is coming. Pointing out the most significant event in the field of pharmaceutical law that took place in 2023 is not difficult: over the past few months, no other law has been as much talked about in the...

Jan. 16, 2024
Katarzyna-Czyzewska-nowe2
Katarzyna Czyzewska

Amendments to the reimbursement law: chaos in the transition period

Given that the legislative process for a major amendment to the Law on Reimbursement of Medicines, Foodstuffs for Special Dietary Purposes and Medical Devices took a long time (it took more than 2 years from the publication of the first draft to the enactment of the law), the entry of DNUR into...

Nov. 28, 2023
Katarzyna-Czyzewska-nowe2
Katarzyna Czyzewska

Parliament begins work on DNUR

For weeks, those involved in drug reimbursement (and not only) in Poland have been wondering whether DNUR - a major amendment to the Reimbursement Act - has a chance of being passed yet in this term of the Sejm. The draft of this law was first published on the pages of the Government Legislation...

June 24, 2023
Katarzyna-Czyzewska-nowe2
Katarzyna Czyżewska

Zapowiedź dużej reformy prawa farmaceutycznego w Unii Europejskiej

W kwietniu b.r. Komisja Europejska opublikowała projekt nowej dyrektywy Unii Europejskiej dotyczącej leków stosowanych u ludzi, która miałaby zastąpić obecną dyrektywę 2001/83; a także projekt rozporządzenia unijnego, które zastąpiłoby obecnie obowiązujące rozporządzenie 726/2004 (o...

June 6, 2023
Katarzyna-Czyzewska-nowe2
Katarzyna Czyzewska

Will the draft of a major amendment to the Reimbursement Act come into effect?

Representatives of the pharmaceutical industry have long been diligently (and with great concern) following the fate of the draft of a major amendment to the Law on Reimbursement of Medicines, Foodstuffs for Special Dietary Purposes and Medical Devices. The legislative process for this...

April 4, 2023
Katarzyna-Czyzewska-nowe2
Katarzyna Czyżewska

Is drug advertising harmful?

Just before the holiday break, on December 21 of last year (already), a draft regulation was sent to public consultations, amending the Regulation of the Minister of Health on the advertising of medicinal products.

Jan. 5, 2022